Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
A Manual for Nations with Incredible Food- Step by step instructions to Utilize Open Record Rewards for Your Potential benefit
- 'All's Fair,' Ryan Murphy's new show starring Kim Kardashian, hit with scathing reviews: 'A girlboss fever dream'
- Nurturing Hacks: Astuteness from Experienced Mothers and Fathers
- 6 Arranging Administrations to Change Your Open air Space
- Unwinding History's Secrets: Looking for the Response to Antiquated Human advancements
- Vote In favor of Your #1 Cell phones
- All that You Really want to Be aware of Dental Inserts Facilities
- What's 'Aawun Buhh' been up to? How a famous 'Got Milk?' ad propelled him to being 'that guy.'
